Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
3 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Phenformin inhibits proliferation, invasion, and angiogenesis of cholangiocarcinoma cells via AMPK-mTOR and HIF-1A pathways.
Naunyn Schmiedebergs Arch Pharmacol. 2020 Sep;393(9):1681-1690. doi: 10.1007/s00210-020-01885-3. Epub 2020 May 7.
Naunyn Schmiedebergs Arch Pharmacol. 2020.
PMID: 32383028
Inhibition of FGFR2 enhances chemosensitivity to gemcitabine in cholangiocarcinoma through the AKT/mTOR and EMT signaling pathways.
Jaidee R, Kukongviriyapan V, Senggunprai L, Prawan A, Jusakul A, Laphanuwat P, Kongpetch S.
Jaidee R, et al.
Life Sci. 2022 May 1;296:120427. doi: 10.1016/j.lfs.2022.120427. Epub 2022 Feb 23.
Life Sci. 2022.
PMID: 35218764
Item in Clipboard
FGF10/FGFR2 Signaling: Therapeutically Targetable Vulnerability in Ligand-responsive Cholangiocarcinoma Cells.
Oeurn K, Jusakul A, Jaidee R, Kukongviriyapan V, Senggunprai L, Prawan A, Kongpetch S.
Oeurn K, et al. Among authors: jaidee r.
In Vivo. 2023 Jul-Aug;37(4):1628-1637. doi: 10.21873/invivo.13248.
In Vivo. 2023.
PMID: 37369494
Free PMC article.
Item in Clipboard
Cite
Cite